CNS Pharmaceuticals Inc.

NASDAQ: CNSP · Real-Time Price · USD
4.96
-1.07 (-17.74%)
At close: Aug 15, 2025, 3:59 PM
5.43
9.48%
After-hours: Aug 15, 2025, 07:47 PM EDT

CNS Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-14.86M -18.85M -15.27M -14.5M
Depreciation & Amortization
3.31K 4.13K 11.76K 13.07K
Stock-Based Compensation
838.96K 1.01M 1.2M 1.72M
Other Working Capital
-59.97K 2.38M 1.46M -1.82M
Other Non-Cash Items
596.11K 498.00 337.25K 714.87K
Deferred Income Tax
n/a n/a n/a -714.87K
Change in Working Capital
-3.69M 3.7M 3.16M -780.02K
Operating Cash Flow
-17.11M -14.14M -10.56M -13.54M
Capital Expenditures
-4.19K -3.9K -4.42K -5.75K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-4.19K -3.9K -4.42K -5.75K
Debt Repayment
-300.81K -438.73K -427.7K -477.49K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-45.42K 2.76M 2.73K 332.75K
Financial Cash Flow
23.03M 4.64M 15.61M 4.51M
Net Cash Flow
5.91M -9.51M 5.05M -9.03M
Free Cash Flow
-17.12M -14.14M -10.56M -13.54M